Risk for complications after prostate biopsy — and consequent revisions to best practice

A new article in Urology (the Gold journal) addresses risk for complications after prostate biopsy in a recent series of > 2,500 biopsies conducted by physicians at a large urology practice in southern California — and what they did as a consequence. … READ MORE …

PSA velocity: is it really an appropriate indicator for prostate biopsy — or not?

Last Friday we noted that a new paper by Vickers et al. has formally recommended that PSA velocity be removed from guidelines on the use of diagnostic data to decide whether a man should have a biopsy to assess his potential risk for prostate cancer. We expressed no opinion on the article at that time … READ MORE …

New AUA “best practice statement” on use of PSA

The American Urological Association’s complete new statement on the use of PSA is now available on the AUA web site. New consumer- and patient-directed information about PSA testing is now available on the web site of the AUA Foundation. … READ MORE …